Industry Press Releases

From the first years of interventional cardiovascular medicine, our industry partners have played an important role in responding to the unmet needs of our speciality. Industry press releases form an inestimable resource for keeping up to date with the industry viewpoint on these latest developments in interventional cardiology. They include information on new medical technologies and treatments, clinical studies, publications and, of course, medical devices.

In this section you will find all the Industry Press releases published on this website with the content listed in chronological order.

These Industry Press Releases do not reflect the opinion of PCR, nor does it engage its responsibility.

Filter By

129 results

MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.

15 May 2024

EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions

16 May 2024

EuroPCR 2024: Elixir Medical’s late-breaking 12-month data demonstrate significant improvement in safety and effectiveness of world’s first site-specific antithrombotic therapeutic compared to DES

14 May 2024

EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years

14 May 2024

TRIA™ polymer surgical valves surpass 200 patient life years

16 Apr 2024

Concept Medical receives US FDA IDE approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

03 Apr 2024

BioCardia and StemCardia announce biotherapeutic delivery partnership

13 Mar 2024

BioCardia reports positive interim results from phase III CardiAMP cell therapy heart failure trial, with compelling data in subgroup with elevated NTproBNP biomarker for heart failure.

04 Mar 2024

First Patient enrolled in the clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft

09 Feb 2024

Robocath performs world’s First-In-Human remote robotic coronary angioplasty between two Chinese cities 1,700 miles apart

14 Dec 2023